Glycome Atlas
method
Also known as site-specific glycosylation analysis, glycopeptide analysis
Plain-language answer
Glycoproteomics is a method that identifies which proteins carry sugar chains, exactly where on the protein those sugars sit, and what the sugar structures are, all at the same time. It keeps the sugar attached to the protein fragment so the analysis links the glycan to its specific location rather than looking at proteins and sugars separately.1
Where a sugar sits on a protein can change how that protein folds, functions, and is recognized by the immune system. By mapping sugars to exact protein sites, glycoproteomics helps researchers understand disease-related changes and supports quality control of protein-based drugs such as therapeutic antibodies.1
Technical detail
Glycoproteomics is the site-specific, large-scale analysis of protein glycosylation, in which intact glycopeptides are enriched from a proteolytic digest and characterized by liquid chromatography-tandem mass spectrometry to assign the glycosylation site, the peptide backbone, and the attached glycan composition simultaneously.12
A typical experiment digests proteins with a protease, enriches the resulting glycopeptides, and analyzes them by LC-MS/MS. Complementary fragmentation methods are combined because collision-based dissociation tends to break glycosidic bonds while electron-transfer dissociation preserves the peptide backbone, so both the site and the glycan can be assigned from the same molecule.12
Assigning intact glycopeptide spectra requires software that matches both peptide and glycan portions against databases, and confidence depends on spectral quality and the completeness of glycan structure libraries. Because occupancy varies, quantitative comparisons report glycoform distributions at each site rather than a single structure.1
Human relevance
Site-specific glycosylation analysis supports characterization of therapeutic proteins and the search for disease biomarkers, though translation of glycopeptide markers into routine clinical assays remains an active area of development.1
Continue exploring
References